Search Results - "Seborova, Karolina"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
  2. 2

    Association of ABC gene profiles with time to progression and resistance in ovarian cancer revealed by bioinformatics analyses by Seborova, Karolina, Vaclavikova, Radka, Soucek, Pavel, Elsnerova, Katerina, Bartakova, Alena, Cernaj, Petr, Bouda, Jiri, Rob, Lukas, Hruda, Martin, Dvorak, Pavel

    Published in Cancer medicine (Malden, MA) (01-02-2019)
    “…Introduction Ovarian cancer (OC) represents a serious disease with high mortality and lack of efficient predictive and prognostic biomarkers. ATP‐binding…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    DNA Repair and Ovarian Carcinogenesis: Impact on Risk, Prognosis and Therapy Outcome by Tomasova, Kristyna, Cumova, Andrea, Seborova, Karolina, Horak, Josef, Koucka, Kamila, Vodickova, Ludmila, Vaclavikova, Radka, Vodicka, Pavel

    Published in Cancers (28-06-2020)
    “…There is ample evidence for the essential involvement of DNA repair and DNA damage response in the onset of solid malignancies, including ovarian cancer…”
    Get full text
    Journal Article
  7. 7

    Non-Coding RNAs as Biomarkers of Tumor Progression and Metastatic Spread in Epithelial Ovarian Cancer by Seborova, Karolina, Vaclavikova, Radka, Rob, Lukas, Soucek, Pavel, Vodicka, Pavel

    Published in Cancers (12-04-2021)
    “…Ovarian cancer is one of the most common causes of death among gynecological malignancies. Molecular changes occurring in the primary tumor lead to metastatic…”
    Get full text
    Journal Article
  8. 8

    Association of lncRNA and transcriptome intersections with response to targeted therapy in metastatic renal cell carcinoma by Tesarova, Tereza, Koucka, Kamila, Vaclavikova, Radka, Seborova, Karolina, Hora, Milan, Hes, Ondrej, Pivovarcikova, Kristyna, Soucek, Pavel, Fiala, Ondrej

    Published in Oncology letters (01-09-2023)
    “…Long non-coding RNAs (lncRNAs) serve an important role in cancer progression and may be used as efficient molecular biomarkers. The present study aimed to…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Telomere length as a predictor of therapy response and survival in patients diagnosed with ovarian carcinoma by Tomasova, Kristyna, Seborova, Karolina, Kroupa, Michal, Horak, Josef, Kavec, Miriam, Vodickova, Ludmila, Rob, Lukas, Hruda, Martin, Mrhalova, Marcela, Bartakova, Alena, Bouda, Jiri, Fleischer, Thomas, Kristensen, Vessela N., Vodicka, Pavel, Vaclavikova, Radka

    Published in Heliyon (15-07-2024)
    “…Impaired telomere length (TL) maintenance in ovarian tissue may play a pivotal role in the onset of epithelial ovarian cancer (OvC). TL in either target or…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Antioxidant, Anti-Inflammatory, and Multidrug Resistance Modulation Activity of Silychristin Derivatives by Viktorová, Jitka, Dobiasová, Simona, Řehořová, Kateřina, Biedermann, David, Káňová, Kristýna, Šeborová, Karolína, Václavíková, Radka, Valentová, Kateřina, Ruml, Tomáš, Křen, Vladimír, Macek, Tomáš

    Published in Antioxidants (14-08-2019)
    “…Silychristin A is the second most abundant compound of silymarin. Silymarin complex was previously described as an antioxidant with multidrug resistance…”
    Get full text
    Journal Article
  14. 14
  15. 15